SEC Form 4 · accession 0001437749-19-001522
CervoMed Inc. · CRVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas E Byrne
Officer — General Counsel
Period of report
Jan 2, 2019
Accepted (ET)
Jan 30, 2019 · 9:06 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053691
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.10 | Jan 3, 2019 | A | 2,667 | A | — | Jan 2, 2029 | Common Stock | 2,667 | 2,667 | D |
Explanation of responses
- F1The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 31, 2019.